PIMOZIDE - Generic Drug Details

What are the generic sources for pimozide and what is the scope of freedom to operate?

Pimozide is the generic ingredient in two branded drugs marketed by Teva and Par Pharm, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for pimozide. One supplier is listed for this compound.

Summary for PIMOZIDE

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	2
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	82
Clinical Trials:	21
Patent Applications:	6,087
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for PIMOZIDE
What excipients (inactive ingredients) are in PIMOZIDE?	PIMOZIDE excipients list
DailyMed Link:	PIMOZIDE at DailyMed

See drug prices for PIMOZIDE

Recent Clinical Trials for PIMOZIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Spaulding Clinical Research LLC	Phase 1
Food and Drug Administration (FDA)	Phase 1
Applied Biology, Inc.	N/A

See all PIMOZIDE clinical trials

Pharmacology for PIMOZIDE

Drug Class

Typical Antipsychotic

Medical Subject Heading (MeSH) Categories for PIMOZIDE

Anti-Dyskinesia Agents

Antipsychotic Agents

Dopamine Antagonists

US Patents and Regulatory Information for PIMOZIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	ORAP	pimozide	TABLET;ORAL	017473-003	Aug 27, 1997		DISCN	Yes	No
Teva	ORAP	pimozide	TABLET;ORAL	017473-001	Jul 31, 1984		DISCN	Yes	No
Par Pharm	PIMOZIDE	pimozide	TABLET;ORAL	204521-002	Sep 28, 2015		RX	No	Yes
Par Pharm	PIMOZIDE	pimozide	TABLET;ORAL	204521-001	Sep 28, 2015		RX	No	No